Last updated 2026-06-18
- Raised $8M Undisclosed Round led by Guangzhou Sino-Israel Biotech Investment Fund (GIBF), Jun 2026
- Raised $15M Series C led by Deep Insight, Nov 2021
- Raised $17M Series B led by Harel Insurance & Finance, Jan 2019
Total raised
$45.0M
Last: Undisclosed Round 2026-06
Stage
Series C
Founded
2016
Headcount
36
HQ
Israel
Sector
Health Tech & Life Sciences
About
Biond Biologics is a biotechnology company developing immunotherapies and an intracellular drug delivery platform for the treatment of cancer patients.
The company uses biologics targeting novel immune evasion mechanisms, discovered through in-house research utilizing real-world patient and tumor samples. Biond Biologics is developing an intracellular delivery platform for biologics (e.g., antibodies or enzymes) inside cells, allowing the company to drug intracellular targets currently considered "undruggable."
Funding history · 4 rounds · $45.0M total
2026-06
Undisclosed Round
$8.0M
2021-11
C Round
$15.0M
2019-01
Date unknown
A Round
$5.0M
Q&A
- What is Biond Biologics' primary focus?
- Biond Biologics is a biotechnology company focused on developing immunotherapies for cancer and auto-immune diseases, as well as an intracellular drug delivery platform.
- When was Biond Biologics founded?
- Biond Biologics was founded in April 2016.
- How many employees does Biond Biologics have?
- Biond Biologics has 11-50 employees.
- What is the total amount of funding Biond Biologics has raised to date?
- Biond Biologics has raised a total of $45,000,000 USD across multiple funding rounds.
- When did Biond Biologics complete its Series B funding round and who were the lead investors?
- Biond Biologics completed its Series B funding round in January 2019, with Harel Insurance & Finance as a lead investor.
- Which investors participated in Biond Biologics' Series C funding round?
- Biond Biologics' Series C funding round in November 2021 was led by Deep Insight and also included.
- Who are the co-founders of Biond Biologics?
- The co-founders of Biond Biologics are Tehila Ben Moshe, who serves as Chairperson & CEO, and Ori Shilo, who is the CFO.
Team · 9
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 PatentsVerified
Tags
pharmaceuticalsimmunologydrug-discoveryoncologyautoimmune-diseasesbiopharmaceuticalcancerpharma-companiesimmunotherapy
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | biondbio.com |
|---|---|
| linkedin.com/company/18156602 |
Identifiers & details
| Founded | 2016-4 |
|---|---|
| Employees (exact) | 36 |
Radar intelligence
Patents
| EPO | 18 |
|---|
Web history (Wayback)
| Domain | biondbio.com |
|---|
Certificate / subdomain footprint
| Subdomains | 4 |
|---|